When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CNCE - Concert Pharma GAAP EPS of -$0.58 beats by $0.01 revenue of $0.08M in-line
Concert Pharmaceuticals Inc.
Concert Pharma press release ( NASDAQ: CNCE ): Q3 GAAP EPS of -$0.58 beats by $0.01 .
Revenue of $0.08M (-84.0% Y/Y) in-line.
Cash, cash equivalents and investments as of September 30, 2022 totaled $148.9 million, compared to $141.6 million as of December 31, 2021. Under its current operating plan, the Company expects its cash, cash equivalents and investments to fund the Company through the second quarter of 2023.